Abstract PO-045: Interleukin 1 receptor accessory protein (IL1RAP) in novel targetable pathway in pancreatic cancer
Yang Zhang(Albert Einstein College of Medicine), Amit Verma(M.J.P. Rohilkhand University), Anirban Maitra(NYU Langone Health), Tushar D. Bhagat(Albert Einstein College of Medicine), Shanisha Gordon-Mitchell(Albert Einstein College of Medicine), Kith Pradhan(Albert Einstein College of Medicine), Ulrich Steidl(Albert Einstein College of Medicine), Xiaoyi Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Beamon Agarwal(Providence College), Gaurav S. Choudhary(Albert Einstein College of Medicine)
Cited by 0
Related Papers
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Recurrent <i>GNAS</i> Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
|Science Translational Medicine|2011|772